Somatic stem cells
US9072719B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 16, 2013 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | May 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating brain tissue damage or a neurodegenerative disease in a subject by obtaining from a subject a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size, and administering to a subject in need thereof an effective amount of the somatic stem cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.